Logo image of AMED

AMEDISYS INC (AMED) Stock Price, Quote, News and Overview

NASDAQ:AMED - Nasdaq - US0234361089 - Common Stock - Currency: USD

92.5  +0.09 (+0.1%)

After market: 92.5 0 (0%)

AMED Quote, Performance and Key Statistics

AMEDISYS INC

NASDAQ:AMED (1/31/2025, 4:02:35 PM)

After market: 92.5 0 (0%)

92.5

+0.09 (+0.1%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
Statistics
52 Week High98.95
52 Week Low82.15
Market Cap3.03B
Shares32.75M
Float32.14M
Yearly Dividend0
Dividend YieldN/A
PE21.56
Fwd PE18.44
Earnings (Next)02-19 2025-02-19/amc
IPO08-17 1994-08-17


AMED short term performance overview.The bars show the price performance of AMED in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 -4

AMED long term performance overview.The bars show the price performance of AMED in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of AMED is 92.5 USD. In the past month the price increased by 2.12%. In the past year, price decreased by -2.39%.

AMEDISYS INC / AMED Daily stock chart

AMED Latest News, Press Releases and Analysis

News Image
2 days ago - MarketBeat

3 Stocks to Gain From Trump’s Family Caregiver Tax Credits

President Trump has spoken about implementing a family caregiver tax credit during his presidential campaign to ease the burden on caregivers, here's who gains.

News Image
16 days ago - Benzinga

UnitedHealth Group Q4 Earnings Preview: First Report Since Insurance CEO's Murder Comes With Questions On Company's Future

UnitedHealth shares a quarterly report for the first time since the death of insurance unit leader Brian Thompson. A look at the estimates and key items to watch.

News Image
a month ago - Bloomberg

UnitedHealth, Amedisys Extend Window to Finish $3.3 Billion Deal

UnitedHealth Group Inc. and Amedisys Inc. gave themselves more time to complete a $3.3 billion deal for the insurer to purchase the home-health provider that’s been challenged by the government.

News Image
3 months ago - Bloomberg

US Justice Department Preps Suit Over UnitedHealth-Amedisys Deal

The US Justice Department is moving to block UnitedHealth Group Inc.’s $3.3 billion purchase of Amedisys Inc. over concerns the deal would harm competition in the market for home-health services, according to people familiar with the matter.

News Image
3 months ago - Amedisys, Inc.

Amedisys Reports Third Quarter 2024 Financial Results

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month...

AMED Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
CI THE CIGNA GROUP 10.76 81.83B
CVS CVS HEALTH CORP 8.89 71.07B
LH LABCORP HOLDINGS INC 17.32 20.89B
DGX QUEST DIAGNOSTICS INC 18.28 18.21B
FMS FRESENIUS MEDICAL CARE-ADR 14.89 14.59B
DVA DAVITA INC 19.84 14.45B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 176.51 14.45B
CHE CHEMED CORP 24.53 8.42B
HIMS HIMS & HERS HEALTH INC 84.73 8.14B
CRVL CORVEL CORP 24.6 5.95B
GH GUARDANT HEALTH INC N/A 5.80B
OPCH OPTION CARE HEALTH INC 25.98 5.26B

About AMED

Company Profile

AMED logo image Amedisys, Inc. engages in the provision of healthcare services. The company is headquartered in Baton Rouge, Louisiana and currently employs 19,000 full-time employees. The firm is engaged in providing care and support in the home. The company delivers clinically distinct care that suits its patients' needs, whether that is home-based recovery and rehabilitation after an operation or injury or care. Its operations involve serving patients across the United States through its three operating divisions: home health, hospice, and high acuity care. Its home health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The home health includes 346 care centers located in 34 states within the United States and the District of Columbia. Its hospice care is designed to provide comfort and support for those who are dealing with a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes.

Company Info

AMEDISYS INC

3854 American Way Ste A, 5959 S Sherwood Forest Blvd

Baton Rouge LOUISIANA 70816 US

CEO: Paul B. Kusserow

Employees: 19000

Company Website: https://www.amedisys.com/

Investor Relations: http://investors.amedisys.com/

Phone: 12252922031

AMED FAQ

What is the stock price of AMED?

The current stock price of AMED is 92.5 USD.


What is the symbol for AMEDISYS INC stock?

The exchange symbol of AMEDISYS INC is AMED and it is listed on the Nasdaq exchange.


On which exchange is AMED stock listed?

AMED stock is listed on the Nasdaq exchange.


Is AMED a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for AMED, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of AMED.


Does AMED stock pay dividends?

AMED does not pay a dividend.


When does AMED stock report earnings?

AMED will report earnings on 2025-02-19, after the market close.


What is the Price/Earnings (PE) ratio of AMED?

The PE ratio for AMED is 21.56. This is based on the reported non-GAAP earnings per share of 4.29 and the current share price of 92.5 USD.


What is the Short Interest ratio of AMED stock?

The outstanding short interest for AMED is 7.02% of its float.


AMED Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to AMED. When comparing the yearly performance of all stocks, AMED is a bad performer in the overall market: 71.47% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AMED Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to AMED. AMED has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AMED Financial Highlights

Over the last trailing twelve months AMED reported a non-GAAP Earnings per Share(EPS) of 4.29. The EPS increased by -4.88% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.57%
ROA 3.88%
ROE 7.23%
Debt/Equity 0.3
Chartmill High Growth Momentum
EPS Q2Q%2.04%
Sales Q2Q%5.65%
EPS 1Y (TTM)-4.88%
Revenue 1Y (TTM)4.19%

AMED Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 54% to AMED. The Buy consensus is the average rating of analysts ratings from 16 analysts.

For the next year, analysts expect an EPS growth of 4.38% and a revenue growth 5.09% for AMED


Ownership
Inst Owners94.06%
Ins Owners2.08%
Short Float %7.02%
Short Ratio3.6
Analysts
Analysts53.75
Price Target99.32 (7.37%)
EPS Next Y4.38%
Revenue Next Year5.09%